A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder - Long-Term Extension Of Study SCA104779 - - Related Studies

A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder - Long-Term Extension Of Study SCA104779 -

This study is currently recruiting participants.

Study NCT00566020. Last updated on November 19, 2008. Information provided by GlaxoSmithKline

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Bipolar Disorder

2	Additional conditions recognized in this trial
		Disease

3	More general conditions related to this trial
		Affective Disorders, Psychotic
		Mental Disorders
		Mood Disorders
		Pathologic Processes

4	Interventions listed in this trial
		BW430C (lamotrigine)

5	Additional drug interventions recognized in this trial
		Lamotrigine

6	More general drug interventions related to this trial
		Anticonvulsants
		Calcium Channel Blockers
		Cardiovascular Agents
		Central Nervous System Agents
		Membrane Transport Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		GlaxoSmithKline